Research programme: phenolic steroid analogues - MIGENIX

Drug Profile

Research programme: phenolic steroid analogues - MIGENIX

Alternative Names: MITO-4565; MX-4565

Latest Information Update: 08 Apr 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator MIGENIX
  • Developer BioWest Therapeutics; MIGENIX
  • Class Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Glaucoma; Neurological disorders; Parkinson's disease; Retinitis pigmentosa

Most Recent Events

  • 13 Jul 2006 Preclinical trials in Neurological disorders in USA (unspecified route)
  • 13 Jul 2006 Preclinical trials in Parkinson's disease in USA (unspecified route)
  • 18 Apr 2006 This programme is still in active development
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top